196 related articles for article (PubMed ID: 22833499)
1. The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches.
Soki FN; Li X; Berry J; Koh A; Sinder BP; Qian X; Kozloff KM; Taichman RS; McCauley LK
J Cell Biochem; 2013 Jan; 114(1):67-78. PubMed ID: 22833499
[TBL] [Abstract][Full Text] [Related]
2. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.
Pozzi S; Vallet S; Mukherjee S; Cirstea D; Vaghela N; Santo L; Rosen E; Ikeda H; Okawa Y; Kiziltepe T; Schoonmaker J; Xie W; Hideshima T; Weller E; Bouxsein ML; Munshi NC; Anderson KC; Raje N
Clin Cancer Res; 2009 Sep; 15(18):5829-39. PubMed ID: 19737962
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
Ubellacker JM; Haider MT; DeCristo MJ; Allocca G; Brown NJ; Silver DP; Holen I; McAllister SS
Breast Cancer Res; 2017 Mar; 19(1):23. PubMed ID: 28264701
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.
Zara S; De Colli M; di Giacomo V; Zizzari VL; Di Nisio C; Di Tore U; Salini V; Gallorini M; Tetè S; Cataldi A
Clin Oral Investig; 2015 Apr; 19(3):601-11. PubMed ID: 25055744
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 2 supports osteoblastic niche cells during hematopoietic homeostasis recovery after bone marrow suppression.
Yoon KA; Son Y; Choi YJ; Kim JH; Cho JY
Cell Commun Signal; 2017 Jun; 15(1):25. PubMed ID: 28662672
[TBL] [Abstract][Full Text] [Related]
6. Osteoclast activity modulates B-cell development in the bone marrow.
Mansour A; Anginot A; Mancini SJ; Schiff C; Carle GF; Wakkach A; Blin-Wakkach C
Cell Res; 2011 Jul; 21(7):1102-15. PubMed ID: 21321604
[TBL] [Abstract][Full Text] [Related]
7. Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone.
Li X; Liao J; Park SI; Koh AJ; Sadler WD; Pienta KJ; Rosol TJ; McCauley LK
Bone; 2011 Jun; 48(6):1354-61. PubMed ID: 21419883
[TBL] [Abstract][Full Text] [Related]
8. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice.
Oguro H; Iwama A; Morita Y; Kamijo T; van Lohuizen M; Nakauchi H
J Exp Med; 2006 Oct; 203(10):2247-53. PubMed ID: 16954369
[TBL] [Abstract][Full Text] [Related]
9. Bmi1 Suppresses Adipogenesis in the Hematopoietic Stem Cell Niche.
Hu T; Kitano A; Luu V; Dawson B; Hoegenauer KA; Lee BH; Nakada D
Stem Cell Reports; 2019 Sep; 13(3):545-558. PubMed ID: 31257132
[TBL] [Abstract][Full Text] [Related]
10. Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning.
Olson TS; Caselli A; Otsuru S; Hofmann TJ; Williams R; Paolucci P; Dominici M; Horwitz EM
Blood; 2013 Jun; 121(26):5238-49. PubMed ID: 23667055
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo.
Lymperi S; Ersek A; Ferraro F; Dazzi F; Horwood NJ
Blood; 2011 Feb; 117(5):1540-9. PubMed ID: 21131587
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.
Méndez-Ferrer S; Michurina TV; Ferraro F; Mazloom AR; Macarthur BD; Lira SA; Scadden DT; Ma'ayan A; Enikolopov GN; Frenette PS
Nature; 2010 Aug; 466(7308):829-34. PubMed ID: 20703299
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence.
Luo Y; Li L; Zou P; Wang J; Shao L; Zhou D; Liu L
Transplantation; 2014 Jan; 97(1):20-9. PubMed ID: 24092377
[TBL] [Abstract][Full Text] [Related]
14. Effect of zoledronate on the responses of osteocytes to acute parathyroid hormone.
Kuroshima S; Elliott KW; Yamashita J
Calcif Tissue Int; 2013 Jun; 92(6):576-85. PubMed ID: 23503790
[TBL] [Abstract][Full Text] [Related]
15. Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.
Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
Clin Oral Investig; 2016 Nov; 20(8):2023-2035. PubMed ID: 26795621
[TBL] [Abstract][Full Text] [Related]
16. Spatial control of bone formation using a porous polymer scaffold co-delivering anabolic rhBMP-2 and anti-resorptive agents.
Yu NY; Gdalevitch M; Murphy CM; Mikulec K; Peacock L; Fitzpatrick J; Cantrill LC; Ruys AJ; Cooper-White JJ; Little DG; Schindeler A
Eur Cell Mater; 2014 Jan; 27():98-109; discussion 109-111. PubMed ID: 24488823
[TBL] [Abstract][Full Text] [Related]
17. IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation.
Caselli A; Olson TS; Otsuru S; Chen X; Hofmann TJ; Nah HD; Grisendi G; Paolucci P; Dominici M; Horwitz EM
Stem Cells; 2013 Oct; 31(10):2193-204. PubMed ID: 23818291
[TBL] [Abstract][Full Text] [Related]
18. Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice.
Orlandi A; Chavakis E; Seeger F; Tjwa M; Zeiher AM; Dimmeler S
Basic Res Cardiol; 2010 Nov; 105(6):703-12. PubMed ID: 20652278
[TBL] [Abstract][Full Text] [Related]
19. [Bone and Stem Cells. Regulation of hematopoietic microenvironment by bone metabolism].
Katayama Y
Clin Calcium; 2014 Apr; 24(4):547-54. PubMed ID: 24681501
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro.
Huang X; Huang S; Guo F; Xu F; Cheng P; Ye Y; Dong Y; Xiang W; Chen A
Mol Med Rep; 2016 Jan; 13(1):613-22. PubMed ID: 26648136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
